Meury William — SEC Form 4 filings
SEC reporting owner CIK 1536778. 9 Form 4 filings on record with FilingPulse; latest filed 2026-07-20.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-02-09 to 2026-07-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INCYTE CORP (INCY) | Chief Executive Officer, Director | 5 | — | — | 9 |
| Karuna Therapeutics, Inc. (KRTX) | President and CEO, Director | 2 | — | — | 5 |
| Syndax Pharmaceuticals Inc (SNDX) | Director | 2 | — | — | 2 |
Form 4 filings — Meury William
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-20 | 4 | INCYTE CORP (INCY) | Grant/award (A): 26,807 @ $0 · Grant/award (A): 80,421 (derivative) @ $0 · Grant/award (A): 77,148 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | INCYTE CORP (INCY) | Tax withholding (F): 4,779 @ $116.86 | EDGAR |
| 2026-04-17 | 4 | INCYTE CORP (INCY) | Option exercise (M): 125,000 @ $0 | EDGAR |
| 2025-07-02 | 4 | INCYTE CORP (INCY) | Grant/award (A): 36,101 @ $0 · Grant/award (A): 108,303 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | INCYTE CORP (INCY) | Grant/award (A): 110,630 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2024-03-18 | 4 | Karuna Therapeutics, Inc. (KRTX) | Disposition to issuer (D): 10,342 @ $330 · Disposition to issuer (D): 19,037 @ $330 · Disposition to issuer (D): 38,688 (derivative) @ $330 · Disposition to issuer (D): 63,065 (derivative) @ $136.81 | EDGAR |
| 2024-02-15 | 4 | Karuna Therapeutics, Inc. (KRTX) | Grant/award (A): 38,688 (derivative) @ $0 | EDGAR |
| 2024-02-09 | 4 | Syndax Pharmaceuticals Inc (SNDX) | Grant/award (A): 17,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1536778 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →